Short Description Alector develops immunotherapies for neurodegeneration to support healthy longevity.
Description Alector is a biotechnology innovator targeting the fundamental mechanisms of aging through immunotherapies for neurodegeneration. The company leverages advancements in neuro‑immunology and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Alector aims to extend healthspan and improve quality of life across the globe.
Address 131 Oyster Point Blvd, Suite 600, South San Francisco, CA, USA